These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9297547

  • 1. ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats.
    Albert DH, Tapang P, Morgan DW, Curtin ML, Sheppard GS, Davidsen SK, Summers JB, Carter GW.
    Inflamm Res; 1997 Aug; 46 Suppl 2():S133-4. PubMed ID: 9297547
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240.
    Sirois MG, Jancar S, Braquet P, Plante GE, Sirois P.
    Prostaglandins; 1988 Nov; 36(5):631-44. PubMed ID: 3238010
    [Abstract] [Full Text] [Related]

  • 8. [The effect of KW-4679, an antiallergic drug, on experimental allergic rhinitis].
    Kaise T, Manabe H, Ohmori K.
    Arerugi; 1995 Oct; 44(10):1229-33. PubMed ID: 8579485
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.
    Jeon SY, Kim EA, Ma YW, Kim JP, Jung TG, Hwang EG.
    Ann Otol Rhinol Laryngol; 2001 Jan; 110(1):83-6. PubMed ID: 11201815
    [Abstract] [Full Text] [Related]

  • 10. Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats.
    Akagi M, Kanoh R, Fukuishi N, Tachibana M, Akagi R.
    Arerugi; 1995 Mar; 44(3 Pt 1):182-8. PubMed ID: 7646374
    [Abstract] [Full Text] [Related]

  • 11. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
    Hatakeyama K, Yano S, Watanabe K.
    Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120
    [Abstract] [Full Text] [Related]

  • 12. Studies on the mechanism of PAF-induced vasopermeability in rat lungs.
    de Lima WT, Kwasniewski FH, Sirois P, Jancar S.
    Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):245-9. PubMed ID: 7784472
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.
    Alabaster VA, Keir RF, Parry MJ, de Souza RN.
    Agents Actions Suppl; 1991 Apr; 34():221-7. PubMed ID: 1793066
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR-900452 in animal models.
    Okamoto M, Yoshida K, Nishikawa M, Hayashi K, Uchida I, Kohsaka M, Aoki H.
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):3005-10. PubMed ID: 3769104
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.